The genetic pathways that underlie the development of the pediatric kidney cancer Wilms tumor provide unique insight into the link between normal development of the kidney and its deregulation during malignant transformation. Inactivating mutations in the WT1 tumor suppressor, a zinc finger transcription factor encoded by multiple alternative splicing variants, underlie a subset of Wilms tumors, pointing to critical transcriptional targets that contribute to kidney development and tumorigenesis. We have used cells with inducible expression of the transcription allyactive isoform, WT1 (-KTS), combined with expression profile analysis to identify physiologically regulated target genes, and we have established a model for WT1-directed cellular differentiation using hematopoietic precursors. Here, we propose to focus on the functional properties of the most abundant isoform, WT1 (+KTS), whose function is unknown.
In Aim I, we will search for endogenous genes whose expression is regulated by WT1 (+KTS), using both hybridization to microarrays and subtractivePCR approaches. The mechanisms by which this WT1 isoform regulates expression of its target genes (transcriptional as well as postulated post-transcriptional mechanisms) will be studied. The functional properties of these downstream effectors and their potential contribution to renal differentiation and Wilms tumorigenesis will be addressed.
In Aim II, we will pursue protein-protein interactions that have been implicated in WT1 (+KTS) function, as well as in its characteristic subnuclear localization within """"""""speckles"""""""". A combination of yeast-two hybrid assays and mass spectrometry sequencing of coprecipitated proteins will be employed, and the functional significance of confirmed interactors will be addressed.
In Aim III, we will study another recently isolated transcription factor, BF2, which is also essential for kidney development, but through a distinct mechanism. Remarkably, BF2 is expressed only in stromal cells of the fetal kidney, yet its inactivation in the mouse suppresses epithelial differentiation without affecting stromal cells themselves. Using inducible expression of BF2 and expression profile analysis, we have identified downstream targets, including secreted growth factors, whose contribution to renal differentiation and to stromal-epithelial interactions will be explored. Taken together, this proposal aims at identifying downstream targets of two transcription factors that are essential to kidney development, defining the mechanism by which these targets are regulated, and studying their potential contribution to Wilms tumorigenesis.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Method to Extend Research in Time (MERIT) Award (R37)
Project #
Application #
Study Section
Pathology B Study Section (PTHB)
Program Officer
Mietz, Judy
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Massachusetts General Hospital
United States
Zip Code
Burger, Alexa; Vasilyev, Aleksandr; Tomar, Ritu et al. (2014) A zebrafish model of chordoma initiated by notochord-driven expression of HRASV12. Dis Model Mech 7:907-13
Liu, Mingzhu; Roth, Anna; Yu, Min et al. (2013) The IGF2 intronic miR-483 selectively enhances transcription from IGF2 fetal promoters and enhances tumorigenesis. Genes Dev 27:2543-8
Kim, Woo Jae; Rivera, Miguel N; Coffman, Erik J et al. (2012) The WTX tumor suppressor enhances p53 acetylation by CBP/p300. Mol Cell 45:587-97
Moisan, Annie; Rivera, Miguel N; Lotinun, Sutada et al. (2011) The WTX tumor suppressor regulates mesenchymal progenitor cell fate specification. Dev Cell 20:583-596
Rothenberg, S Michael; Mohapatra, Gayatry; Rivera, Miguel N et al. (2010) A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers. Cancer Res 70:2158-64
Wells, Julie; Rivera, Miguel N; Kim, Woo Jae et al. (2010) The predominant WT1 isoform (+KTS) encodes a DNA-binding protein targeting the planar cell polarity gene Scribble in renal podocytes. Mol Cancer Res 8:975-85
Aiden, Aviva Presser; Rivera, Miguel N; Rheinbay, Esther et al. (2010) Wilms tumor chromatin profiles highlight stem cell properties and a renal developmental network. Cell Stem Cell 6:591-602
Rivera, Miguel N; Kim, Woo Jae; Wells, Julie et al. (2009) The tumor suppressor WTX shuttles to the nucleus and modulates WT1 activity. Proc Natl Acad Sci U S A 106:8338-43
Diederichs, Sven; Jung, Stephanie; Rothenberg, S Michael et al. (2008) Coexpression of Argonaute-2 enhances RNA interference toward perfect match binding sites. Proc Natl Acad Sci U S A 105:9284-9
Rivera, Miguel N; Kim, Woo Jae; Wells, Julie et al. (2007) An X chromosome gene, WTX, is commonly inactivated in Wilms tumor. Science 315:642-5

Showing the most recent 10 out of 36 publications